Evidence map›Paper›PMID 38118016›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project.

Ahmed Taha Aboushady, Mohammad Julhas Sujan, Kien Pham, Adam Clark, Florian Marks, Marianne Holm, Hea Sun Joh, Nimesh Poudyal, John Stelling

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed Taha AboushadyBrigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-8245-6591
Mohammad Julhas SujanInternational Vaccine Institute, Seoul, Republic of Korea.
Kien PhamInternational Vaccine Institute, Seoul, Republic of Korea.
Adam ClarkBrigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.
Marianne HolmInternational Vaccine Institute, Seoul, Republic of Korea.
Hea Sun JohInternational Vaccine Institute, Seoul, Republic of Korea.
Nimesh PoudyalInternational Vaccine Institute, Seoul, Republic of Korea.
John StellingBrigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a growing global public health challenge associated with 4.95 million deaths in 2019 and an estimated 10 million deaths per year by 2050 in the absence of coordinated action. A robust AMR surveillance system is therefore required to avert such a scenario. Based on an analysis of country-level AMR data in 8 Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) countries, we present a list of key recommendations to strengthen AMR surveillance. We propose 10 primary considerations under 3 broad categories, including recommendations on (1) laboratory and testing practices, (2) data management and analysis, and (3) data use.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialAsiaHumansLaboratoriesPublic HealthAnti-Bacterial Agentsantimicrobial resistancedata and laboratory quality managementSouth AsiaSoutheast Asiasurveillance

Identifiers

PMID38118016
PMCPMC10732552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.